GPT and metabolic dysfunction-associated steatotic liver disease: A meta-analysis that aimed to evaluate the effect of SGLT2-i on NAFLD based on the changes in liver enzyme levels and liver fat volume concluded that SGLT2-i can significantly decrease ALT levels and liver fat, accompanied by weight loss [41].